The predominant biological hypothesis for a neurochemical defect in schizophrenia is currently the socalled "dopamine (DA) hypothesis." In its simplest form, this hypothesis states that schizophrenia may be related to a relative excess of DA-dependent neuronal activity. It is derived from pharmacologic evidence that drugs that decrease DA activity (e.g., the phenothiazines) may be antipsychotic...